Additional information
| Raw Material | Sitaggliptin |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | Low risk |
| Lab Test | Monitoring of blood glucose and HbA1c levels |
| Also known as | 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate (1:1) |
| Blood pressure | Generally has a neutral effect on blood pressure |
| Trade name | Januvia |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | Sitagliptin phosphate |
| Formula | C16H15F6N5O•H3PO4 |
| Substance class | Dipeptidyl peptidase-4 (DPP-4) inhibitor |
| Main action | Increases insulin release and decreases glucagon levels in a glucose-dependent manner |
| Half-life | Approximately 12.4 hours |
| Dosage (medical) | Typically 100 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Improves blood glucose control |
| Side effects | Nasopharyngitis, headache, upper respiratory tract infection, hypoglycemia (when used with other antidiabetics) |
| Use in sports | Not typically used in sports |
| Manufacturer | MERCK |
| Packing | 28 tabs (100 mg/tab) |
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Fostimon (Merional) 150 IU HMG IBSA
Champix 56 tabs Pfizer
Fostimon (Merional) 75 (HMG) IBSA
FACTIVE 320 mg Abdi Ibragim 

Reviews
There are no reviews yet.